2025-522446-51-00CompletedPhase 1
Assessment of the safety and effects on the body of investigational products when used on psoriatic skin
Source: EU CTIS (euclinicaltrials.eu) · Last updated 27 Mar 2026
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (actual)
- First submitted
- 11 Aug 2025
- Start date
- 17 Oct 2025
- Lead sponsor
- Bacoba AG
- Diseases
- Psoriasis
- EU CT number
- 2025-522446-51-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 15
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (4)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dr. Niesmann And Dr. Othlinghaus GbR | Bochum | Germany | Completed |
| Klinische Forschung Dresden GmbH | Dresden | Germany | Completed |
| SRH Wald-Klinikum Gera GmbH | Gera | Germany | Completed |
| Eurofins bioskin GmbH | Hamburg | Germany | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.